Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CG Oncology
CG Oncology
Everyone's Talking About These 2 Biotech IPO Stocks
Motley Fool
Sun, 02/25/24 - 08:55 pm
biotech
IPOs
Kyverna Therapeutics
CG Oncology
CG Oncology prices larger-than-expected $380M IPO in hopeful sign for biotech
BioPharma Dive
Wed, 01/24/24 - 11:36 pm
CG Oncology
IPOs
cancer
oncology
2024 Brings Surprising Early Surge of Biotech IPOs
BioSpace
Fri, 01/19/24 - 09:43 am
biotech
IPOs
CG Oncology
Alto Neuroscience
ArriVent Biopharma
Kyverna Therapeutics
Metagenomi
CG Oncology aims for $209M IPO, as more biotechs eye path to public markets
Fierce Biotech
Thu, 01/18/24 - 11:11 am
CG Oncology
IPOs
oncology
bladder cancer
CG Oncology plans IPO plunge ahead of phase 3 bladder cancer drug readout
Fierce Biotech
Wed, 01/3/24 - 09:35 am
CG Oncology
IPOs
bladder cancer
In a year with few biotech IPOs, ‘crossover’ financings are hard to find
BioPharma Dive
Wed, 08/16/23 - 10:00 am
CG Oncology
cancer
IPOs
funding
crossover financing
CG brings back the crossover round, reeling in $105M to fund phase 3 bladder cancer trial
Fierce Biotech
Wed, 08/2/23 - 11:30 am
CG Oncology
funding
bladder cancer
clinical trials
#ASCO2022 roundup: CG Oncology builds on head-turning combo data; EQRx doesn’t have a way into US markets
Endpoints
Mon, 06/6/22 - 10:31 am
ASCO 2022
CG Oncology
Merck
Keytruda
EQRx
sugemalimab
Oncolytic immunotherapy biotech CG Oncology nabs $47M round for late-stage cancer push
Fierce Biotech
Fri, 12/11/20 - 11:11 am
CG Oncology
Oncolytics
funding